Cite

HARVARD Citation

    Cassaniti, I. et al. (2021). Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection. American journal of transplantation. 21 (4), pp. 1622-1628. [Online]. 
  
Back to record